Pinnacle Medicines
PrivateLast Round
Series B
Mar 26, 2026
Total Funding Raised
$179M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Pinnacle Medicines is a biotechnology company that develops oral peptide therapeutics designed to deliver biologic-level efficacy with the convenience of oral dosing for immunology and cardiometabolic diseases.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pinnacle Medicines Comparables
Compare Pinnacle Medicines with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Unnatural Products | 82% | |
| Vilya | 81% | |
| Orbis Medicines | 78% |
Pinnacle Medicines Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Mar 26, 2026 |
Pinnacle Medicines Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| RA Capital Management | Series B |
| OrbiMed | Series B, Series A |
| Logos Capital | Series B |
| Foresite Capital | Series B |
| Lilly Asia Ventures | Series B |
| Hankang Capital | Series B |
| Qiming Venture Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 22, 2026
Open roles increased to 4, 4x the trailing average.
- Jun 2, 2026
Grew 24% QoQ from 17 to 21 employees.
Recent news
Latest coverage and updates
- is_developingJul 30, 2026
Pinnacle Medicines, Inc. is planning to develop new generation of oral peptide medicines.
Pinnacle Medicines Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Pinnacle Medicines's valuation, stock price, and market status.
Is Pinnacle Medicines a public or private company?
Pinnacle Medicines is a private company.
What is the current stock price of Pinnacle Medicines?
Pinnacle Medicines is a private company with no public stock price. No recent secondary market data is available.
How much is Pinnacle Medicines worth (valuation)?
Valuation information for Pinnacle Medicines is not publicly available.
Can I buy Pinnacle Medicines stock?
Pinnacle Medicines shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Pinnacle Medicines's last funding round?
Pinnacle Medicines's most recent funding round was Series B on March 26, 2026.
Who are the main investors in Pinnacle Medicines?
Key investors in Pinnacle Medicines include Foresite Capital, Lilly Asia Ventures.
Will Pinnacle Medicines IPO soon?
No public IPO plans have been announced for Pinnacle Medicines.
How can I track Pinnacle Medicines secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Pinnacle Medicines's secondary market activity and sign up for updates.